Fund detail
Dodge & Cox
large-active, value, lo
Quarters
52
2021-12-31
$161.45B
Positions
197
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-12-31
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
Price is the latest implied close from the selected quarter's 13F (value ÷ shares). Est. Cost is a running average that assumes each quarter's trades cleared near the midpoint of consecutive 13F closes (or yfinance VWAP when available). Most accurate for slow accumulators, least accurate for activists who build positions in a few days.
| # | Issuer | Value ↓ | Weight | Shares | Share Δ | Share Δ % | Prev Weight | First Held | Price | Est. Cost | Unrealized % | Status |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Anheuser-Busch InBev SA/NV BUD | $910.7M | 0.56% | 15,040,157 | +15,040,157 | 2021-12-31 | $61 | ~$61 | +0.00% | |||
| 2 | XP Inc | $263.8M | 0.16% | 9,178,691 | +9,178,691 | 2021-12-31 | $29 | ~$29 | +0.00% | |||
| 3 | II-VI Inc | $190.1M | 0.12% | 2,782,089 | +2,782,089 | 2021-12-31 | $68 | ~$68 | +0.00% | |||
| 4 | Regeneron Pharmaceuticals Inc REGN | $176.3M | 0.11% | 279,122 | +279,122 | 2021-12-31 | $632 | ~$632 | +0.00% | |||
| 5 | Cintas Corp CTAS | $222K | 0.00% | 500 | +500 | 2021-12-31 | $444 | ~$444 | +0.00% | |||
| 6 | DOMINION ENERGY INC D | $213K | 0.00% | 2,712 | +2,712 | 2013-06-30 | $79 | ~$57 | +38.27% |